Acute Sinusitis Market - Global Outlook and Forecast 2021-2027

April 2021 | 104 pages | ID: A2B08BA630C0EN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Acute Sinusitis in Global, including the following market information:

Global Acute Sinusitis Market Revenue, 2016-2021, 2022-2027, ($ millions)

Global top five companies in 2020 (%)

The global Acute Sinusitis market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Acute Sinusitis companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Acute Sinusitis Market, By Type, 2016-2021, 2022-2027 ($ millions)

Global Acute Sinusitis Market Segment Percentages, By Type, 2020 (%)

• OTC Pain Relievers
• Saline Nasal Spray
• Nasal Corticosteroids
• Others

China Acute Sinusitis Market, By Application, 2016-2021, 2022-2027 ($ millions)

China Acute Sinusitis Market Segment Percentages, By Application, 2020 (%)

• Hospital
• Clinic

Global Acute Sinusitis Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)

Global Acute Sinusitis Market Segment Percentages, By Region and Country, 2020 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Total Acute Sinusitis Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)

Total Acute Sinusitis Market Competitors Revenues Share in Global, by Players 2020 (%)

Further, the report presents profiles of competitors in the market, including the following:

• Teva Pharmaceutical
• Sun Pharmaceutical
• Sanofi
• Pfizer
• Novartis
• Merck
• Johnson & Johnson
• Fresenius Kabi
• Eli Lilly and Company
• Dr. Reddy's Laboratories
• Bristol-Myers Squibb
• Bionorica
• Bayer
• AstraZeneca
• Amgen
• Abbott

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Acute Sinusitis Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Acute Sinusitis Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL ACUTE SINUSITIS OVERALL MARKET SIZE

2.1 Global Acute Sinusitis Market Size: 2021 VS 2027
2.2 Global Acute Sinusitis Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Acute Sinusitis Players in Global Market
3.2 Top Global Acute Sinusitis Companies Ranked by Revenue
3.3 Global Acute Sinusitis Revenue by Companies
3.4 Top 3 and Top 5 Acute Sinusitis Companies in Global Market, by Revenue in 2020
3.5 Global Companies Acute Sinusitis Product Type
3.6 Tier 1, Tier 2 and Tier 3 Acute Sinusitis Players in Global Market
  3.6.1 List of Global Tier 1 Acute Sinusitis Companies
  3.6.2 List of Global Tier 2 and Tier 3 Acute Sinusitis Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Acute Sinusitis Market Size Markets, 2021 & 2027
  4.1.2 OTC Pain Relievers
  4.1.3 Saline Nasal Spray
  4.1.4 Nasal Corticosteroids
  4.1.5 Others
4.2 By Type - Global Acute Sinusitis Revenue & Forecasts
  4.2.1 By Type - Global Acute Sinusitis Revenue, 2016-2021
  4.2.2 By Type - Global Acute Sinusitis Revenue, 2022-2027
  4.2.3 By Type - Global Acute Sinusitis Revenue Market Share, 2016-2027

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Acute Sinusitis Market Size, 2021 & 2027
  5.1.2 Hospital
  5.1.3 Clinic
5.2 By Application - Global Acute Sinusitis Revenue & Forecasts
  5.2.1 By Application - Global Acute Sinusitis Revenue, 2016-2021
  5.2.2 By Application - Global Acute Sinusitis Revenue, 2022-2027
  5.2.3 By Application - Global Acute Sinusitis Revenue Market Share, 2016-2027

6 SIGHTS BY REGION

6.1 By Region - Global Acute Sinusitis Market Size, 2021 & 2027
6.2 By Region - Global Acute Sinusitis Revenue & Forecasts
  6.2.1 By Region - Global Acute Sinusitis Revenue, 2016-2021
  6.2.2 By Region - Global Acute Sinusitis Revenue, 2022-2027
  6.2.3 By Region - Global Acute Sinusitis Revenue Market Share, 2016-2027
6.3 North America
  6.3.1 By Country - North America Acute Sinusitis Revenue, 2016-2027
  6.3.2 US Acute Sinusitis Market Size, 2016-2027
  6.3.3 Canada Acute Sinusitis Market Size, 2016-2027
  6.3.4 Mexico Acute Sinusitis Market Size, 2016-2027
6.4 Europe
  6.4.1 By Country - Europe Acute Sinusitis Revenue, 2016-2027
  6.4.2 Germany Acute Sinusitis Market Size, 2016-2027
  6.4.3 France Acute Sinusitis Market Size, 2016-2027
  6.4.4 U.K. Acute Sinusitis Market Size, 2016-2027
  6.4.5 Italy Acute Sinusitis Market Size, 2016-2027
  6.4.6 Russia Acute Sinusitis Market Size, 2016-2027
  6.4.7 Nordic Countries Acute Sinusitis Market Size, 2016-2027
  6.4.8 Benelux Acute Sinusitis Market Size, 2016-2027
6.5 Asia
  6.5.1 By Region - Asia Acute Sinusitis Revenue, 2016-2027
  6.5.2 China Acute Sinusitis Market Size, 2016-2027
  6.5.3 Japan Acute Sinusitis Market Size, 2016-2027
  6.5.4 South Korea Acute Sinusitis Market Size, 2016-2027
  6.5.5 Southeast Asia Acute Sinusitis Market Size, 2016-2027
  6.5.6 India Acute Sinusitis Market Size, 2016-2027
6.6 South America
  6.6.1 By Country - South America Acute Sinusitis Revenue, 2016-2027
  6.6.2 Brazil Acute Sinusitis Market Size, 2016-2027
  6.6.3 Argentina Acute Sinusitis Market Size, 2016-2027
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Acute Sinusitis Revenue, 2016-2027
  6.7.2 Turkey Acute Sinusitis Market Size, 2016-2027
  6.7.3 Israel Acute Sinusitis Market Size, 2016-2027
  6.7.4 Saudi Arabia Acute Sinusitis Market Size, 2016-2027
  6.7.5 UAE Acute Sinusitis Market Size, 2016-2027

7 PLAYERS PROFILES

7.1 Teva Pharmaceutical
  7.1.1 Teva Pharmaceutical Corporate Summary
  7.1.2 Teva Pharmaceutical Business Overview
  7.1.3 Teva Pharmaceutical Acute Sinusitis Major Product Offerings
  7.1.4 Teva Pharmaceutical Acute Sinusitis Revenue in Global (2016-2021)
  7.1.5 Teva Pharmaceutical Key News
7.2 Sun Pharmaceutical
  7.2.1 Sun Pharmaceutical Corporate Summary
  7.2.2 Sun Pharmaceutical Business Overview
  7.2.3 Sun Pharmaceutical Acute Sinusitis Major Product Offerings
  7.2.4 Sun Pharmaceutical Acute Sinusitis Revenue in Global (2016-2021)
  7.2.5 Sun Pharmaceutical Key News
7.3 Sanofi
  7.3.1 Sanofi Corporate Summary
  7.3.2 Sanofi Business Overview
  7.3.3 Sanofi Acute Sinusitis Major Product Offerings
  7.3.4 Sanofi Acute Sinusitis Revenue in Global (2016-2021)
  7.3.5 Sanofi Key News
7.4 Pfizer
  7.4.1 Pfizer Corporate Summary
  7.4.2 Pfizer Business Overview
  7.4.3 Pfizer Acute Sinusitis Major Product Offerings
  7.4.4 Pfizer Acute Sinusitis Revenue in Global (2016-2021)
  7.4.5 Pfizer Key News
7.5 Novartis
  7.5.1 Novartis Corporate Summary
  7.5.2 Novartis Business Overview
  7.5.3 Novartis Acute Sinusitis Major Product Offerings
  7.5.4 Novartis Acute Sinusitis Revenue in Global (2016-2021)
  7.5.5 Novartis Key News
7.6 Merck
  7.6.1 Merck Corporate Summary
  7.6.2 Merck Business Overview
  7.6.3 Merck Acute Sinusitis Major Product Offerings
  7.6.4 Merck Acute Sinusitis Revenue in Global (2016-2021)
  7.6.5 Merck Key News
7.7 Johnson & Johnson
  7.7.1 Johnson & Johnson Corporate Summary
  7.7.2 Johnson & Johnson Business Overview
  7.7.3 Johnson & Johnson Acute Sinusitis Major Product Offerings
  7.4.4 Johnson & Johnson Acute Sinusitis Revenue in Global (2016-2021)
  7.7.5 Johnson & Johnson Key News
7.8 Fresenius Kabi
  7.8.1 Fresenius Kabi Corporate Summary
  7.8.2 Fresenius Kabi Business Overview
  7.8.3 Fresenius Kabi Acute Sinusitis Major Product Offerings
  7.8.4 Fresenius Kabi Acute Sinusitis Revenue in Global (2016-2021)
  7.8.5 Fresenius Kabi Key News
7.9 Eli Lilly and Company
  7.9.1 Eli Lilly and Company Corporate Summary
  7.9.2 Eli Lilly and Company Business Overview
  7.9.3 Eli Lilly and Company Acute Sinusitis Major Product Offerings
  7.9.4 Eli Lilly and Company Acute Sinusitis Revenue in Global (2016-2021)
  7.9.5 Eli Lilly and Company Key News
7.10 Dr. Reddy's Laboratories
  7.10.1 Dr. Reddy's Laboratories Corporate Summary
  7.10.2 Dr. Reddy's Laboratories Business Overview
  7.10.3 Dr. Reddy's Laboratories Acute Sinusitis Major Product Offerings
  7.10.4 Dr. Reddy's Laboratories Acute Sinusitis Revenue in Global (2016-2021)
  7.10.5 Dr. Reddy's Laboratories Key News
7.11 Bristol-Myers Squibb
  7.11.1 Bristol-Myers Squibb Corporate Summary
  7.11.2 Bristol-Myers Squibb Business Overview
  7.11.3 Bristol-Myers Squibb Acute Sinusitis Major Product Offerings
  7.11.4 Bristol-Myers Squibb Acute Sinusitis Revenue in Global (2016-2021)
  7.11.5 Bristol-Myers Squibb Key News
7.12 Bionorica
  7.12.1 Bionorica Corporate Summary
  7.12.2 Bionorica Business Overview
  7.12.3 Bionorica Acute Sinusitis Major Product Offerings
  7.12.4 Bionorica Acute Sinusitis Revenue in Global (2016-2021)
  7.12.5 Bionorica Key News
7.13 Bayer
  7.13.1 Bayer Corporate Summary
  7.13.2 Bayer Business Overview
  7.13.3 Bayer Acute Sinusitis Major Product Offerings
  7.13.4 Bayer Acute Sinusitis Revenue in Global (2016-2021)
  7.13.5 Bayer Key News
7.14 AstraZeneca
  7.14.1 AstraZeneca Corporate Summary
  7.14.2 AstraZeneca Business Overview
  7.14.3 AstraZeneca Acute Sinusitis Major Product Offerings
  7.14.4 AstraZeneca Acute Sinusitis Revenue in Global (2016-2021)
  7.14.5 AstraZeneca Key News
7.15 Amgen
  7.15.1 Amgen Corporate Summary
  7.15.2 Amgen Business Overview
  7.15.3 Amgen Acute Sinusitis Major Product Offerings
  7.15.4 Amgen Acute Sinusitis Revenue in Global (2016-2021)
  7.15.5 Amgen Key News
7.16 Abbott
  7.16.1 Abbott Corporate Summary
  7.16.2 Abbott Business Overview
  7.16.3 Abbott Acute Sinusitis Major Product Offerings
  7.16.4 Abbott Acute Sinusitis Revenue in Global (2016-2021)
  7.16.5 Abbott Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Acute Sinusitis Market Opportunities & Trends in Global Market
Table 2. Acute Sinusitis Market Drivers in Global Market
Table 3. Acute Sinusitis Market Restraints in Global Market
Table 4. Key Players of Acute Sinusitis in Global Market
Table 5. Top Acute Sinusitis Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Acute Sinusitis Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Acute Sinusitis Revenue Share by Companies, 2016-2021
Table 8. Global Companies Acute Sinusitis Product Type
Table 9. List of Global Tier 1 Acute Sinusitis Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Acute Sinusitis Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type – Global Acute Sinusitis Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Acute Sinusitis Revenue in Global (US$, Mn), 2016-2021
Table 13. By Type - Acute Sinusitis Revenue in Global (US$, Mn), 2022-2027
Table 14. By Application – Global Acute Sinusitis Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - Acute Sinusitis Revenue in Global (US$, Mn), 2016-2021
Table 16. By Application - Acute Sinusitis Revenue in Global (US$, Mn), 2022-2027
Table 17. By Region – Global Acute Sinusitis Revenue, (US$, Mn), 2021 VS 2027
Table 18. By Region - Global Acute Sinusitis Revenue (US$, Mn), 2016-2021
Table 19. By Region - Global Acute Sinusitis Revenue (US$, Mn), 2022-2027
Table 20. By Country - North America Acute Sinusitis Revenue, (US$, Mn), 2016-2021
Table 21. By Country - North America Acute Sinusitis Revenue, (US$, Mn), 2022-2027
Table 22. By Country - Europe Acute Sinusitis Revenue, (US$, Mn), 2016-2021
Table 23. By Country - Europe Acute Sinusitis Revenue, (US$, Mn), 2022-2027
Table 24. By Region - Asia Acute Sinusitis Revenue, (US$, Mn), 2016-2021
Table 25. By Region - Asia Acute Sinusitis Revenue, (US$, Mn), 2022-2027
Table 26. By Country - South America Acute Sinusitis Revenue, (US$, Mn), 2016-2021
Table 27. By Country - South America Acute Sinusitis Revenue, (US$, Mn), 2022-2027
Table 28. By Country - Middle East & Africa Acute Sinusitis Revenue, (US$, Mn), 2016-2021
Table 29. By Country - Middle East & Africa Acute Sinusitis Revenue, (US$, Mn), 2022-2027
Table 30. Teva Pharmaceutical Corporate Summary
Table 31. Teva Pharmaceutical Acute Sinusitis Product Offerings
Table 32. Teva Pharmaceutical Acute Sinusitis Revenue (US$, Mn), (2016-2021)
Table 33. Sun Pharmaceutical Corporate Summary
Table 34. Sun Pharmaceutical Acute Sinusitis Product Offerings
Table 35. Sun Pharmaceutical Acute Sinusitis Revenue (US$, Mn), (2016-2021)
Table 36. Sanofi Corporate Summary
Table 37. Sanofi Acute Sinusitis Product Offerings
Table 38. Sanofi Acute Sinusitis Revenue (US$, Mn), (2016-2021)
Table 39. Pfizer Corporate Summary
Table 40. Pfizer Acute Sinusitis Product Offerings
Table 41. Pfizer Acute Sinusitis Revenue (US$, Mn), (2016-2021)
Table 42. Novartis Corporate Summary
Table 43. Novartis Acute Sinusitis Product Offerings
Table 44. Novartis Acute Sinusitis Revenue (US$, Mn), (2016-2021)
Table 45. Merck Corporate Summary
Table 46. Merck Acute Sinusitis Product Offerings
Table 47. Merck Acute Sinusitis Revenue (US$, Mn), (2016-2021)
Table 48. Johnson & Johnson Corporate Summary
Table 49. Johnson & Johnson Acute Sinusitis Product Offerings
Table 50. Johnson & Johnson Acute Sinusitis Revenue (US$, Mn), (2016-2021)
Table 51. Fresenius Kabi Corporate Summary
Table 52. Fresenius Kabi Acute Sinusitis Product Offerings
Table 53. Fresenius Kabi Acute Sinusitis Revenue (US$, Mn), (2016-2021)
Table 54. Eli Lilly and Company Corporate Summary
Table 55. Eli Lilly and Company Acute Sinusitis Product Offerings
Table 56. Eli Lilly and Company Acute Sinusitis Revenue (US$, Mn), (2016-2021)
Table 57. Dr. Reddy's Laboratories Corporate Summary
Table 58. Dr. Reddy's Laboratories Acute Sinusitis Product Offerings
Table 59. Dr. Reddy's Laboratories Acute Sinusitis Revenue (US$, Mn), (2016-2021)
Table 60. Bristol-Myers Squibb Corporate Summary
Table 61. Bristol-Myers Squibb Acute Sinusitis Product Offerings
Table 62. Bristol-Myers Squibb Acute Sinusitis Revenue (US$, Mn), (2016-2021)
Table 63. Bionorica Corporate Summary
Table 64. Bionorica Acute Sinusitis Product Offerings
Table 65. Bionorica Acute Sinusitis Revenue (US$, Mn), (2016-2021)
Table 66. Bayer Corporate Summary
Table 67. Bayer Acute Sinusitis Product Offerings
Table 68. Bayer Acute Sinusitis Revenue (US$, Mn), (2016-2021)
Table 69. AstraZeneca Corporate Summary
Table 70. AstraZeneca Acute Sinusitis Product Offerings
Table 71. AstraZeneca Acute Sinusitis Revenue (US$, Mn), (2016-2021)
Table 72. Amgen Corporate Summary
Table 73. Amgen Acute Sinusitis Product Offerings
Table 74. Amgen Acute Sinusitis Revenue (US$, Mn), (2016-2021)
Table 75. Abbott Corporate Summary
Table 76. Abbott Acute Sinusitis Product Offerings
Table 77. Abbott Acute Sinusitis Revenue (US$, Mn), (2016-2021)

List Of Figures

LIST OF FIGURES

Figure 1. Acute Sinusitis Segment by Type
Figure 2. Acute Sinusitis Segment by Application
Figure 3. Global Acute Sinusitis Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Acute Sinusitis Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Acute Sinusitis Revenue, 2016-2027 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Acute Sinusitis Revenue in 2020
Figure 8. By Type - Global Acute Sinusitis Revenue Market Share, 2016-2027
Figure 9. By Application - Global Acute Sinusitis Revenue Market Share, 2016-2027
Figure 10. By Region - Global Acute Sinusitis Revenue Market Share, 2016-2027
Figure 11. By Country - North America Acute Sinusitis Revenue Market Share, 2016-2027
Figure 12. US Acute Sinusitis Revenue, (US$, Mn), 2016-2027
Figure 13. Canada Acute Sinusitis Revenue, (US$, Mn), 2016-2027
Figure 14. Mexico Acute Sinusitis Revenue, (US$, Mn), 2016-2027
Figure 15. By Country - Europe Acute Sinusitis Revenue Market Share, 2016-2027
Figure 16. Germany Acute Sinusitis Revenue, (US$, Mn), 2016-2027
Figure 17. France Acute Sinusitis Revenue, (US$, Mn), 2016-2027
Figure 18. U.K. Acute Sinusitis Revenue, (US$, Mn), 2016-2027
Figure 19. Italy Acute Sinusitis Revenue, (US$, Mn), 2016-2027
Figure 20. Russia Acute Sinusitis Revenue, (US$, Mn), 2016-2027
Figure 21. Nordic Countries Acute Sinusitis Revenue, (US$, Mn), 2016-2027
Figure 22. Benelux Acute Sinusitis Revenue, (US$, Mn), 2016-2027
Figure 23. By Region - Asia Acute Sinusitis Revenue Market Share, 2016-2027
Figure 24. China Acute Sinusitis Revenue, (US$, Mn), 2016-2027
Figure 25. Japan Acute Sinusitis Revenue, (US$, Mn), 2016-2027
Figure 26. South Korea Acute Sinusitis Revenue, (US$, Mn), 2016-2027
Figure 27. Southeast Asia Acute Sinusitis Revenue, (US$, Mn), 2016-2027
Figure 28. India Acute Sinusitis Revenue, (US$, Mn), 2016-2027
Figure 29. By Country - South America Acute Sinusitis Revenue Market Share, 2016-2027
Figure 30. Brazil Acute Sinusitis Revenue, (US$, Mn), 2016-2027
Figure 31. Argentina Acute Sinusitis Revenue, (US$, Mn), 2016-2027
Figure 32. By Country - Middle East & Africa Acute Sinusitis Revenue Market Share, 2016-2027
Figure 33. Turkey Acute Sinusitis Revenue, (US$, Mn), 2016-2027
Figure 34. Israel Acute Sinusitis Revenue, (US$, Mn), 2016-2027
Figure 35. Saudi Arabia Acute Sinusitis Revenue, (US$, Mn), 2016-2027
Figure 36. UAE Acute Sinusitis Revenue, (US$, Mn), 2016-2027
Figure 37. Teva Pharmaceutical Acute Sinusitis Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. Sun Pharmaceutical Acute Sinusitis Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. Sanofi Acute Sinusitis Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. Pfizer Acute Sinusitis Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 41. Novartis Acute Sinusitis Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 42. Merck Acute Sinusitis Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 43. Johnson & Johnson Acute Sinusitis Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 44. Fresenius Kabi Acute Sinusitis Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 45. Eli Lilly and Company Acute Sinusitis Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 46. Dr. Reddy's Laboratories Acute Sinusitis Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 47. Bristol-Myers Squibb Acute Sinusitis Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 48. Bionorica Acute Sinusitis Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 49. Bayer Acute Sinusitis Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 50. AstraZeneca Acute Sinusitis Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 51. Amgen Acute Sinusitis Revenue Year Over Year Growth (US$, Mn) & (2016-2021)